Group 1 - The company has confirmed that the energetic materials production line 001 has completed linked trial runs and has partially started production [2] - The production line 003 is currently undergoing engineering design and site leveling work [2]

Group 1 - The company, Guotai Group, has completed the trial operation of its energetic materials production line 001, which utilizes advanced technology for design and construction [2] - The production line 001 has begun partial material input, indicating progress in production capabilities [2] - The engineering design and site leveling for production line 003 are currently underway, suggesting ongoing expansion in production capacity [2]

Group 1 - The company has established a propylene oxide facility with an annual capacity of 300,000 tons, utilizing the HPPO (Hydrogen Peroxide Propylene Oxide) technology developed by Evonik and ThyssenKrupp, which is noted for its environmental friendliness, advanced technology, and minimal by-products [2]

Core Viewpoint - The company has successfully achieved stable performance indicators and increasing production and sales of its hydrocarbon resin since 2025, with expectations for greater order capacity due to rising downstream demand and a new project set to begin trial production in mid-2026 [1] Group 1 - The company has been supplying hydrocarbon resin in bulk since 2025, with stable performance metrics [1] - Production and sales of hydrocarbon resin are expected to increase quarterly [1] - A project for producing 20,000 tons of electronic materials for high-speed communication substrates is anticipated to start trial production by the end of June 2026 [1] Group 2 - The company has greater order acceptance capabilities due to increasing downstream demand [1] - Specific agreements and arrangements with customers are considered trade secrets and cannot be disclosed [1]

（文章来源：证券日报） 证券日报网讯 2月24日，金能科技在互动平台回答投资者提问时表示，截至2026年2月13日，公司股东 户数共34171户。 ...

（文章来源：证券日报） 证券日报网讯 2月24日，飞凯材料在互动平台回答投资者提问时表示，公司医药中间体产品主要为各类 卤代烃产品，主要有溴乙腈、溴乙酸叔丁酯、环己基苯、氯代环己烷等，多应用在抗病毒药物、抗生素 以及心脑血管医药领域。 ...

Group 1 - The core point of the article is that Huahua Co., Ltd. has reported a total of 12,619 shareholders as of February 13, 2026, which includes both ordinary accounts and margin trading accounts [2]

Group 1 - The company, Beihua Co., announced the redemption of a large-denomination certificate of deposit from China Construction Bank, with a redemption amount of 256 million yuan [1] - The investment period for the certificate of deposit was from November 19, 2025, to February 19, 2026, and the company earned an interest income of 582,500 yuan from this investment [1] - The funds from the redemption will be used for investment projects funded by raised capital, and this action will not affect the progress of these projects or the company's normal production and operations [1]

Core Viewpoint - Dongyue Silicon Materials (300821) reported that as of February 13, 2026, the total number of shareholders (including both ordinary accounts and margin trading accounts) is 67,882 [1] Group 1 - The company actively engages with investors through an interactive platform [1] - The total number of shareholders indicates a significant level of interest and participation in the company's stock [1] - The data reflects the company's shareholder structure as of a specific date, providing insights into its market presence [1]

国家知识产权局信息显示，埃克森美孚（惠州）化工有限公司申请一项名为"在C4装置开车/停车阶段预 防冷脆的方法"的专利，公开号CN121557419A，申请日期为2026年1月。 专利摘要显示，本发明涉及一种在C4装置开车/停车阶段预防冷脆的方法，其中在开始引入作为原料的 液态C4之前/在开始排出作为产物的液态C4之后，向所述装置的容器内引入过热气态C4，从而使得所述 容器内的气体基本为气态C4。本发明可以避免该装置中局部温度过低现象的产生，从而消除了因装置 材料冷脆而带来的安全风险。 本文源自：市场资讯 天眼查资料显示，埃克森美孚（惠州）化工有限公司，成立于2019年，位于惠州市，是一家以从事化学 原料和化学制品制造业为主的企业。企业注册资本200000万美元。通过天眼查大数据分析，埃克森美孚 （惠州）化工有限公司参与招投标项目99次，专利信息71条，此外企业还拥有行政许可385个。 作者：情报员 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 ...